Abstract
Thanks in part to the development of effective osteoporosis-fighting drugs during the 1990s, more and more peope are being treated for osteoporosis. However, researchers are quick to point out that the disease is still “grossly undertreated.”
The full text of this article is not available online. Order this issue »